CP and metastatic neoplasm: Thus, we investigated the possible role of CDK5 in influencing the CP effects in nonseminoma TC cell models based on a shared approach for the treatment of metastatic disease, the need to bypass CP resistance and the emerging role of CDKs in TC [16,17].